Christopher Upton

Array ( [id] => 6761208 [patent_doc_number] => 20030124570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Methods for screening for proteins comprising a signal sequence' [patent_app_type] => new [patent_app_number] => 10/205921 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7275 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124570.pdf [firstpage_image] =>[orig_patent_app_number] => 10205921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783470 [patent_doc_number] => 20030064917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Methods and compositions for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 10/180959 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 27065 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064917.pdf [firstpage_image] =>[orig_patent_app_number] => 10180959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801567 [patent_doc_number] => 20030096732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Telomerase expression repressor proteins and methods of using the same' [patent_app_type] => new [patent_app_number] => 10/177744 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22073 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096732.pdf [firstpage_image] =>[orig_patent_app_number] => 10177744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838738 [patent_doc_number] => 20030036078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'P5CRs as modifiers of the p53 pathway and methods of use' [patent_app_type] => new [patent_app_number] => 10/161418 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13455 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036078.pdf [firstpage_image] =>[orig_patent_app_number] => 10161418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801582 [patent_doc_number] => 20030096747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder' [patent_app_type] => new [patent_app_number] => 10/155785 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27720 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096747.pdf [firstpage_image] =>[orig_patent_app_number] => 10155785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856672 [patent_doc_number] => 07374930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'GLP-1 gene delivery for the treatment of type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 10/153470 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6802 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374930.pdf [firstpage_image] =>[orig_patent_app_number] => 10153470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783070 [patent_doc_number] => 20030064517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Expression vectors, transfection systems, and method of use thereof' [patent_app_type] => new [patent_app_number] => 10/146356 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13577 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064517.pdf [firstpage_image] =>[orig_patent_app_number] => 10146356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736832 [patent_doc_number] => 07033792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/143575 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18466 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033792.pdf [firstpage_image] =>[orig_patent_app_number] => 10143575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6648797 [patent_doc_number] => 20030213013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Fructose polymer synthesis in monocot plastids' [patent_app_type] => new [patent_app_number] => 10/140410 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12022 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20030213013.pdf [firstpage_image] =>[orig_patent_app_number] => 10140410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725745 [patent_doc_number] => 20030208057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Mammalian genes modulated during fasting and feeding' [patent_app_type] => new [patent_app_number] => 10/166349 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39673 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20030208057.pdf [firstpage_image] =>[orig_patent_app_number] => 10166349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861069 [patent_doc_number] => 20030092077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Human sperm activator peptides' [patent_app_type] => new [patent_app_number] => 10/138089 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3742 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092077.pdf [firstpage_image] =>[orig_patent_app_number] => 10138089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 724622 [patent_doc_number] => 07045508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products' [patent_app_type] => utility [patent_app_number] => 10/135164 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7304 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045508.pdf [firstpage_image] =>[orig_patent_app_number] => 10135164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296129 [patent_doc_number] => 20040214264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Nucleic acid molecule encoding a variant DDAH 1 protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/125456 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5389 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214264.pdf [firstpage_image] =>[orig_patent_app_number] => 10125456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6552090 [patent_doc_number] => 20020111293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Modulation of memory, learning and/or anxiety states' [patent_app_type] => new [patent_app_number] => 10/121624 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10819 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111293.pdf [firstpage_image] =>[orig_patent_app_number] => 10121624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743098 [patent_doc_number] => 20060088823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification' [patent_app_type] => utility [patent_app_number] => 10/473173 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22512 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088823.pdf [firstpage_image] =>[orig_patent_app_number] => 10473173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679168 [patent_doc_number] => 20030167484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions' [patent_app_type] => new [patent_app_number] => 10/109616 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22202 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20030167484.pdf [firstpage_image] =>[orig_patent_app_number] => 10109616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656578 [patent_doc_number] => 20030009780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Transgenic mice containing 5-HT5B serotonin receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 10/109532 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25459 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009780.pdf [firstpage_image] =>[orig_patent_app_number] => 10109532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656576 [patent_doc_number] => 20030009779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Transgenic mice containing ubiquitin enzyme gene disruptions' [patent_app_type] => new [patent_app_number] => 10/108755 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21759 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009779.pdf [firstpage_image] =>[orig_patent_app_number] => 10108755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6757696 [patent_doc_number] => 20030005473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'OGR1 gene disruptions, compositions and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/109533 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26023 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20030005473.pdf [firstpage_image] =>[orig_patent_app_number] => 10109533 [rel_patent_id] =>[rel_patent_doc_number] =>)